EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Changes in Descending Pain Modulation During Anti–Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and Spondyloarthritis

Anne-Priscille Trouvin iD, Arielle Simunek, Joël Coste, Terkia Medkour, Alice Combier, Lucile Poiroux, François Vidal, Sandrine Carvès iD, Didier Bouhassira, Serge Perrot

Arthritis & Rheumatology · 2025

DOI: 10.1002/art.43084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Anne-Priscille Trouvin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Le Groupe Hospitalier Universitaire Paris Centre Cochin and Université Paris Cité, Paris, France, and Inserm U987, Université de Versailles Saint Que…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Spondylarthritis, Antirheumatic Agents, Pain Threshold. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EFIC-Grunenthal Grant, Cercle d'Etude de la Douleur en Rhumatologie (CEDR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In rheumatoid arthritis (RA) and spondyloarthritis (SpA), managing persistent pain remains challenging. Little is known regarding impaired pain pathways in these patients and the impact of biologic disease‐modifying antirheumatic drugs (bDMARDs). The objective of the Rheumatism Pain Inhibitory Descending Pathways study was to assess pain thresholds and descending pain modulation in patients with active RA or SpA following introduction of a tumor necrosis factor inhibitor (TNFi).

Methods

Patients with active disease (50 with RA and 50 with SpA) naive to bDMARDs or targeted synthetic DMARDs and starting a TNFi were included. Patients were observed for six months after TNFi initiation with clinical, psychological, and pain assessment. At all visits, participants underwent quantitative sensory testing with heat and cold pain thresholds and descending inhibition by conditioned pain modulation (CPM). Descending pain control (CPM effect) was assessed as the change in heat pain threshold (°C) following a conditioning stimulus.

Results

Of the 100 patients (59 women, mean ± SD age 45.8 ± 14.6 years), 74 completed the six‐month follow‐up. Thermal pain thresholds did not significantly change during follow‐up. CPM effect improved significantly during follow‐up (mean ± SD 0.25 ±2.57°C at baseline and 2.96 ± 2.50°C at six months; P < 0.001). At the end of follow‐up, the mean CPM effect was significantly higher in patients without significant pain compared with patients with persistent pain (>3 of 10 on the Brief Pain Inventory) (mean ± SD 3.25 ± 2.68°C vs 2.47 ± 2.11°C; P = 0.04) and in patients achieving remission or low disease activity compared with patients with active rheumatism (mean ± SD 3.31 ± 2.68°C vs 2.18 ± 1.87°C; P = 0.01).

Conclusion

In active inflammatory rheumatisms, impaired descending pain modulation, but not thermal pain thresholds, is improved after TNFi treatment, suggesting a possible effect of TNFi on central pain modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidSpondylarthritisAntirheumatic AgentsPain ThresholdTumor Necrosis Factor-alphaTumor Necrosis Factor InhibitorsHumansFemaleMiddle AgedMaleProspective StudiesAdultPain Measurement

Substanzen

Antirheumatic AgentsTumor Necrosis Factor-alphaTumor Necrosis Factor Inhibitors

Autor:innen und Institutionen

  • Le Groupe Hospitalier Universitaire Paris Centre Cochin and Université Paris Cité, Paris, France, and Inserm U987, Université de Versailles Saint Quentin, Paris-Saclay University, AP-HP, Ambroise Paré Hospital, Boulogne…
  • Le Groupe Hospitalier Universitaire Paris Centre Cochin and Université Paris Cité, Paris, France.
  • Le Groupe Hospitalier Universitaire Paris Centre Cochin, Paris, France.
  • Le Groupe Hospitalier Universitaire Paris-Saclay Ambroise Paré, Boulogne-Billancourt, France.
  • Inserm U987, Université de Versailles Saint Quentin, Paris-Saclay University, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, France.

ORCID-Profile: Anne-Priscille Trouvin, Sandrine Carvès

Förderung

  • EFIC-Grunenthal Grant
  • Cercle d'Etude de la Douleur en Rhumatologie (CEDR)

Zitieren

APA

Trouvin, A. P., Simunek, A., Coste, J., Medkour, T., Combier, A., Poiroux, L., Vidal, F., Carvès, S., Bouhassira, D., & Perrot, S. (2025). Changes in Descending Pain Modulation During Anti–Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and Spondyloarthritis. Arthritis & Rheumatology. https://doi.org/10.1002/art.43084

Vancouver

Trouvin AP, Simunek A, Coste J, Medkour T, Combier A, Poiroux L, et al. Changes in Descending Pain Modulation During Anti–Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and Spondyloarthritis. Arthritis & Rheumatology. 2025. doi:10.1002/art.43084

BibTeX
@article{Trouvin2025,
  author = {Trouvin, Anne-Priscille and Simunek, Arielle and Coste, Joël and Medkour, Terkia and Combier, Alice and Poiroux, Lucile and Vidal, François and Carvès, Sandrine and Bouhassira, Didier and Perrot, Serge},
  title = {Changes in Descending Pain Modulation During Anti–Tumor Necrosis Factor Therapy: A Prospective Study in Rheumatoid Arthritis and Spondyloarthritis},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  doi = {10.1002/art.43084}
}
Kostenlos starten →